Over the past two decades, research programs funded by the National Institute on Drug Abuse (NIDA) have produced dramatic advances in our understanding of drug abuse and addiction. These new advances have led to the development of an array of new treatments and evidence-based therapies. However, the efficacy of these therapies for drug addiction has been demonstrated primarily in specialized research settings, with somewhat restricted patient populations. In order to fulfill NIDA’s total mission, advances achieved in drug abuse research centers must reach patients in the community-based settings where most treatment is provided.

Beginning in 2000, in an effort to enhance the delivery of scientifically based treatments to drug abuse patients, NIDA established the National Drug Abuse Treatment Clinical Trials Network (CTN). The CTN is at the cutting-edge of improving the quality of drug treatment in the United States by introducing scientifically proven treatments in community-based treatment programs. It has enabled rapid, concurrent testing of a wide range of promising behavioral therapies, medications, and their combined use across a range of populations, treatment settings, and community environments. Along with the CTN studies, SSTAR is also involved in pharmaceutical research studies, which allow us to be on the forefront of revolutionary drug treatment options.

Clinical Trials NetworkEarly in the CTN development, SSTAR was invited to partner with Mclean Hospital of Harvard University and four other community treatment programs (CTPs) across New England to form what is known as the Northern New England Node. SSTAR is currently involved in three clinical trials, and has completed five others to date. These programs not only afford us the professional and intellectual fulfillment of working with the nation’s best academic researchers, but also allow us to provide no cost, cutting-edge treatment to our patients. If you are interested in learning more about research at SSTAR, please email us at: You can also click the tabs on the left to find out more about the ongoing research studies here at SSTAR.

Journal of Substance Abuse Treatment Research Articles

Linkage to Primary Care for Persons First Receiving Injectable Naltrexone During Inpatient Opioid Detoxification

Gender Differences in the Life Concerns of Person Seeking Alcohol Detoxification

Adverse Childhood Experiences in an Opioid Dependent Population

Research Projects at SSTAR


Currently recruiting!

This is a (National Institute of Health) NIH study working with Butler Hospital to evaluate the effectiveness of linking individuals entering detox and seeking Buprenorphine to the outpatient buprenorphine clinic.  This study recruits from SSTAR Inpatient Programs.


Funded by the (National Institute on Drug Abuse) NIDA to compare the effectiveness of Vivitrol (XR-NTX) to Suboxone(buprenorphine/naloxone) to prevent opioid use and addiction.  Participants who are currently abusing opiates are recruited from SSTAR inpatient programs.

If you, or someone you know, may be interested in being involved in this research study contact Michelle Rapoza (508)324-3522.

This study is no longer enrolling.